佛慈制药
(002644)
| 流通市值：39.58亿 | | | 总市值：39.58亿 |
| 流通股本：5.11亿 | | | 总股本：5.11亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 351,622,449.61 | 362,369,100.93 | 365,338,610.71 | 406,040,604.7 |
| 应收票据及应收账款 | 343,973,094.8 | 327,882,275.47 | 359,772,626.14 | 285,487,599.46 |
| 应收账款 | 343,973,094.8 | 327,882,275.47 | 359,772,626.14 | 285,487,599.46 |
| 应收款项融资 | 45,395,807.46 | 29,664,020.67 | 78,731,929.42 | 97,163,546.77 |
| 预付款项 | 16,980,207.27 | 17,218,331.12 | 13,219,186.61 | 17,062,096.92 |
| 其他应收款合计 | 37,249,690.65 | 36,081,145.12 | 36,630,896.16 | 42,098,745.16 |
| 存货 | 405,498,888.06 | 418,135,714.66 | 379,869,353.52 | 369,720,187.96 |
| 其他流动资产 | 25,861,114.36 | 25,927,552.66 | 19,282,332.69 | 21,296,541.87 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,226,581,252.21 | 1,217,278,140.63 | 1,252,844,935.25 | 1,238,869,322.84 |
| 非流动资产: | | | | |
| 长期股权投资 | 57,546,825.06 | 60,656,787.9 | 61,493,830.98 | 64,103,030.98 |
| 投资性房地产 | 7,803,812.61 | 7,908,166.23 | 8,012,393.43 | 8,116,873.48 |
| 固定资产 | 1,021,858,630.11 | 1,039,106,917.53 | 1,041,356,917 | 1,056,198,751.95 |
| 在建工程 | 3,789,261.28 | 2,626,417.24 | 3,885,240.75 | 3,299,498.18 |
| 使用权资产 | 1,597,488.33 | 1,903,626.45 | 2,027,045.2 | 2,337,536.94 |
| 无形资产 | 77,653,093.2 | 78,552,506.17 | 79,317,596.04 | 79,551,495.79 |
| 商誉 | 9,009,586.84 | 9,009,586.84 | 9,009,586.84 | 9,009,586.84 |
| 长期待摊费用 | 5,981,476.88 | 5,492,213.94 | 10,645,151 | 7,654,824.09 |
| 递延所得税资产 | 53,832,447.09 | 55,772,493.32 | 51,404,898.7 | 53,648,272.25 |
| 其他非流动资产 | 5,931,102.7 | 6,114,238.27 | 7,504,750.72 | 5,313,021.02 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,245,003,724.1 | 1,267,142,953.89 | 1,274,657,410.66 | 1,289,232,891.52 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,471,584,976.31 | 2,484,421,094.52 | 2,527,502,345.91 | 2,528,102,214.36 |
| 流动负债: | | | | |
| 短期借款 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| 应付票据及应付账款 | 261,503,730.93 | 297,117,035.49 | 304,539,339.84 | 310,372,778.5 |
| 其中：应付票据 | 5,172,114.56 | - | 5,400,000 | 27,434,000 |
| 应付账款 | 256,331,616.37 | 297,117,035.49 | 299,139,339.84 | 282,938,778.5 |
| 合同负债 | 28,071,729.93 | 31,181,370.87 | 44,366,471.04 | 47,017,257.29 |
| 应付职工薪酬 | 3,029,454 | 3,078,574 | 3,382,624.18 | 4,185,589.19 |
| 应交税费 | 23,682,905.38 | 19,524,088.42 | 35,076,676.13 | 35,125,433.42 |
| 其他应付款合计 | 64,395,548.97 | 40,997,711.32 | 44,538,986.23 | 40,458,857.09 |
| 一年内到期的非流动负债 | 14,861,168.66 | 14,073,467.71 | 14,731,850.46 | 14,685,728.18 |
| 其他流动负债 | 3,662,344.8 | 3,691,521.82 | 5,767,641.24 | 5,841,866.89 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 409,206,882.67 | 419,663,769.63 | 462,403,589.12 | 467,687,510.56 |
| 非流动负债: | | | | |
| 租赁负债 | 1,354,973.17 | 1,459,793.1 | 1,391,006.2 | 1,345,791.72 |
| 长期应付款 | 13,200,000 | 13,200,000 | 13,200,000 | 26,600,000 |
| 递延收益 | 251,894,755.27 | 256,584,553.63 | 261,274,351.99 | 260,964,150.35 |
| 递延所得税负债 | 1,965,378.07 | 2,842,524 | 2,161,887.94 | 3,074,827.24 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 268,415,106.51 | 274,086,870.73 | 278,027,246.13 | 291,984,769.31 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 677,621,989.18 | 693,750,640.36 | 740,430,835.25 | 759,672,279.87 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 510,657,000 | 510,657,000 | 510,657,000 | 510,657,000 |
| 资本公积 | 337,378,624.27 | 337,378,624.27 | 337,378,624.27 | 337,378,624.27 |
| 其他综合收益 | 192,780.92 | 197,205.55 | -58,737.67 | -58,737.67 |
| 专项储备 | 1,134,763.8 | 1,268,476.58 | 1,268,476.58 | 1,268,476.58 |
| 盈余公积 | 119,928,027.47 | 119,928,027.47 | 119,928,027.47 | 119,928,027.47 |
| 未分配利润 | 799,950,645.14 | 796,972,982.3 | 794,584,641.39 | 776,197,417.12 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,769,241,841.6 | 1,766,402,316.17 | 1,763,758,032.04 | 1,745,370,807.77 |
| 少数股东权益 | 24,721,145.53 | 24,268,137.99 | 23,313,478.62 | 23,059,126.72 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,793,962,987.13 | 1,790,670,454.16 | 1,787,071,510.66 | 1,768,429,934.49 |
| 负债和股东权益合计 | 2,471,584,976.31 | 2,484,421,094.52 | 2,527,502,345.91 | 2,528,102,214.36 |
| 公告日期 | 2024-10-26 | 2024-08-27 | 2024-04-10 | 2024-04-10 |
| 审计意见(境内) | | | | 标准无保留意见 |